Cantor Fitzgerald’s Replimune Group REPL Stock Holding History

Cantor Fitzgerald’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-200,000	Closed	-$1.86M	–	506
2025 Q2	$1.86M	Buy	+200,000	New	+$1.75M	0.03%	109

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Cantor Fitzgerald's REPL Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Replimune Group (REPL) in Q3 2025, closing a stake of 125,667 shares — an estimated $1.17M sold.

Cantor Fitzgerald first reported a position in REPL in Q2 2024 and held it in 3 quarters. The position peaked at $1.31M in Q2 2024. 163 funds tracked by Wall St. Rank hold REPL as of Q3 2025.

Cantor Fitzgerald reported no remaining Replimune Group position as of Q3 2025 after selling out during the quarter.
Cantor Fitzgerald sold 125,667 Replimune Group shares in Q3 2025, an estimated $1.17M.
Cantor Fitzgerald first reported a position in Replimune Group in Q2 2024 and held it in 3 quarters.
Cantor Fitzgerald's Replimune Group position peaked at $1.31M in Q2 2024.
163 funds tracked by Wall St. Rank held Replimune Group as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.